Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 7/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | GHSR | Q92847 | 2/20 | 0.32 |
| ▸ | KRAS | P01116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26645120 | 1.00 | EGFR (0.35) | EGFRMAPK1GHSRKRAS | |
| SCHEMBL30622329 | 0.90 | TMEM97 (0.33) | EGFRMAPK1GHSRKRAS | |
| SCHEMBL26645220 | 0.90 | TMEM97 (0.33) | EGFRMAPK1GHSRKRAS | |
| SCHEMBL26645209 | 0.90 | GHSR (0.33) | GHSR | |
| SCHEMBL26645769 | 0.87 | EGFR (0.33) | EGFRMAPK1GHSR | |
| SCHEMBL30622334 | 0.87 | EGFR (0.33) | EGFRMAPK1GHSR | |
| SCHEMBL30622814 | 0.85 | USP30 (0.32) | GHSR | |
| SCHEMBL30622384 | 0.85 | BRD4 (0.37) | EGFRMAPK1 | |
| SCHEMBL30622397 | 0.85 | BRD4 (0.37) | EGFRMAPK1 | |
| SCHEMBL26644821 | 0.85 | BRD4 (0.37) | EGFRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | claimed |
| WO-2023213882-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | claimed |
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213882-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | disclosed |